Evidence for Mitochondrial K+ Channels and Their Role in Cardioprotection

Circulation Research

Volumn 94, Issue 4, 2004, Pages 420-432

  O'Rourke, Brian ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

ATP sensitive potassium channels; Calcium activated potassium channels; Ischemia; Mitochondria; Reperfusion

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CALCIUM ACTIVATED POTASSIUM CHANNEL; DIAZOXIDE; FLAVOPROTEIN; POTASSIUM CHANNEL;

APOPTOSIS; BIOENERGY; ELECTROPHYSIOLOGY; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; NERVE EXCITABILITY; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ADENOSINE; ANIMALS; CATTLE; DIAZOXIDE; ENERGY METABOLISM; HUMANS; ION TRANSPORT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MEMBRANE PROTEINS; MICE; MITOCHONDRIA, HEART; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNELS; RATS;

EID: 1542343927     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000117583.66950.43     Document Type: Review

References (135)

1. + channels in cardiac muscle. Nature. 1983; 305:147-148.
2. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE 3rd, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science. 1995;268:423-426.
3. + channels. Neuron. 1996;16: 1011-1107.
4. Inagaki N, Tsuura Y, Namba N, Masuda K, Gonoi T, Horie M, Seino Y, Mizuta M, Seino S. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem. 1995;270:5691-5694.
5. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270: 1166-1170.
6. Nichols CG, Ripoll C, Lederer WJ. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Res. 1991;68:280-287.
7. Smallwood JK, Ertel PJ, Steinberg MI. Modification by glibenclamide of the electrophysiological consequences of myocardial ischaemia in dogs and rabbits. Naunyn Schmiedebergs Arch Pharmacol. 1990;342: 214-220.
8. Gumina RJ, Pucar D, Bast P, Hodgson DM, Kurtz CE, Dzeja PP, Miki T, Seino S, Terzic A. Knockout of Kir6.2 negates ischemic preconditioning-induced protection of myocardial energetics. Am J Physiol Heart Circ Physiol. 2003;284:H2106-H2113.
9. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H, Seino S. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002;8: 466-472.
10. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, Seino S, Alekseev AE, Terzic A. Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci U S A. 2002;99:13278-13283.
11. ATP channels. Stroke. 2003;34: 164-170.
12. ATP channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci USA. 2001;98:11760-11764.
13. + channels. Prog Biophys Mol Biol. 2003;81:133-176.
14. + channel in the mitochondrial inner membrane. Nature. 1991;352:244-247.
15. + channel from rat liver and beef heart mitochondria. J Biol Chem. 1992;267:26062-26069.
16. + channel. Pol J Pharmacol. 1993;45:437-443.
17. Garlid KD. Cation transport in mitochondria: the potassium cycle. Biochim Biophys Acta. 1996;1275:123-126.
18. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81: 1072-1082.
19. Liu Y, Sato T, O'Rourke B, Marbán E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
20. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG, Darbenzio RB. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiovasc Res. 1995;30:731-738.
21. Grover GJ, Garlid KD. ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. J Mol Cell Cardiol. 2000;32: 677-695.
22. ATP opener with no peripheral vasodilator or cardiac action potential shortening activity. J Pharmacol Exp Ther. 2001;297:1184-1192.
23. ATP channels: role in cardioprotection. Cardiovasc Res. 2002;55:429-437.
24. ATP channels in preconditioning. Circ Res. 2000;87:845-855.
25. + channels and myocardial preconditioning. Circ Res. 1999;84: 973-979.
26. Mironova GD, Skarga YY, Grigoriev SM, Negoda AE, Kolomytkin OV, Marinov BS. Reconstitution of the mitochondrial ATP-dependent potassium channel into bilayer lipid membrane. J Bioenerg Biomembr. 1999;31:159-163.
27. + transport with a 53 kilodalton mitochondrial protein. Biochem Biophys Res Commun. 1988;153:224-230.
28. ATP channel face the cytosol. Biochim Biophys Acta. 1997;1321:128-136.
29. Zhang DX, Chen YF, Campbell WB, Zou AP, Gross GJ, Li PL. Characteristics and superoxide-induced activation of reconstituted myocardial mitochondrial ATP-sensitive potassium channels. Circ Res. 2001;89:1177-1183.
30. ATP channel by redox agents. Biochim Biophys Acta. 1999;1410:91-96.
31. ATP channel. Membr Cell Biol. 2001;14:663-671.
32. + channels reconstituted in lipid bilayers. Am J Physiol Heart Circ Physiol. 2003;284:H1865-H1871.
33. Tanaka K, Weihrauch D, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mitochondrial adenosine triphosphate-regulated potassium channel opening acts as a trigger for isoflurane-induced preconditioning by generating reactive oxygen species. Anesthesiology. 2003;98:935-943.
34. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J Biol Chem. 2001;276: 33369-33374.
35. ATP channel by long-chain acyl-CoA esters and activation by guanine nucleotides. J Biol Chem. 1996;271:32084-32088.
36. ATP channel as a receptor for potassium channel openers. J Biol Chem. 1996;271:8796-8799.
37. Brierley GP, Jurkowitz M, Chavez E, Jung DW. Energy-dependent contraction of swollen heart mitochondria. J Biol Chem. 1977;252: 7932-7939.
38. Garlid KD, Paucek P. The mitochondrial potassium cycle. IUBMB Life. 2001;52:153-158.
39. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem. 1998;273:13578-13582.
40. Garlid KD, Beavis AD. Evidence for the existence of an inner membrane anion channel in mitochondria. Biochim Biophys Acta. 1986; 853:187-204.
41. Hassinen I, Chance B. Oxidation-reduction properties of the mitochondrial flavoprotein chain. Biochem Biophys Res Commun. 1968;31: 895-900.
42. Chance B, Salkovitz IA, Kovach AG. Kinetics of mitochondrial flavoprotein and pyridine nucleotide in perfused heart. Am J Physiol. 1972;223:207-218.
43. ATP channels in ischemic cardioprotection. Circulation. 2000;101: 2418-2423.
44. Sasaki N, Sato T, Ohler A, O'Rourke B, Marbán E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation. 2000;101:439-445.
45. Seharaseyon J, Ohler A, Sasaki N, Fraser H, Sato T, Johns DC, O'Rourke B, Marbán E. Molecular composition of mitochondrial ATP-sensitive potassium channels probed by viral Kir gene transfer. J Mol Cell Cardiol. 2000;32:1923-1930.
46. Sato T, Sasaki N, O'Rourke B, Marbán E. Adenosine primes the opening of mitochondrial ATP-sensitive potassium channels: a key step in ischemic preconditioning? Circulation. 2000;102:800-805.
47. Sasaki N, Murata M, Guo Y, Jo SH, Ohler A, Akao M, O'Rourke B, Xiao RP, Bolli R, Marbán E. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning. Circulation. 2003;107:1183-1188.
48. Mocanu MM, Maddock HL, Baxter GF, Lawrence CL, Standen NB, Yellon DM. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation. 2001;103:3111-3116.
49. Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, Marbán E. Mitochondrial ATP-dependent potassium channels: viable candidate effectors of ischemic preconditioning. Ann N Y Acad Sci. 1999;874: 27-37.
50. Sato T, Sasaki N, O'Rourke B, Marbán E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.
51. + channels by protein kinase C. Circ Res. 1998;83: 110-114.
52. 2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ Res. 2001;89:891-898.
53. + channel of heart mitochondria. Am J Physiol Heart Circ Physiol. 2001;280:H649-H657.
54. Debska G, Kicinska A, Skalska J, Szewczyk A, May R, Elger CE, Kunz WS. Opening of potassium channels modulates mitochondrial function in rat skeletal muscle. Biochim Biophys Acta. 2002;1556:97-105.
55. Minners J, van den Bos EJ, Yellon DM, Schwalb H, Opie LH, Sack MN. Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res. 2000;47:68-73.
56. + channels modulate cardiac mitochondrial function. Am J Physiol. 1998;275:H1567-H1576.
57. Schafer G, Wegener C, Portenhauser R, Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem Pharmacol. 1969;18: 2678-2681.
58. Schafer G, Portenhauser R, Trolp R. Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide, I: action on succinate dehydrogenase and TCA-cycle oxidations. Biochem Pharmacol. 1971; 20:1271-1280.
59. Grimmsmann T, Rustenbeck I. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria. Br J Pharmacol. 1998;123:781-788.
60. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol. 2002;545:961-974.
61. Portenhauser R, Schafer G, Trolp R. Inhibition of mitochondrial metabolism by the diabetogenic thiadiazine diazoxide, II: interaction with energy conservation and ion transport. Biochem Pharmacol. 1971;20: 2623-2632.
62. Lenzen S, Panten U. Characterization of succinate dehydrogenase and α-glycerophosphate dehydrogenase in pancreatic islets. Biochem Med. 1983;30:349-356.
63. ATP channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542:735-741.
64. ATP channel change the function of mitochondria in situ? J Biol Chem. 2000;275:37291-37295.
65. Lembert N, Idahl LA, Ammon HP. K-ATP channel independent effects of pinacidil on ATP production in isolated cardiomyocyte or pancreatic β-cell mitochondria. Biochem Pharmacol. 2003;65:1835-1841.
66. ATP channels in rat mitochondria. J Physiol. 2003;547:893-902.
67. ATP channel. Am J Physiol Heart Circ Physiol. 2001;280:H2406-H2411.
68. Horiguchi T, Kis B, Rajapakse N, Shimizu K, Busija DW. Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke. 2003;34:1015-1020.
69. + channel activity. Circulation. 2003;108(suppl IV):IV-212.
70. Ozcan C, Bienengraeber M, Dzeja PP, Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 2002;282:H531-H539.
71. Birincioglu M, Yang XM, Critz SD, Cohen MV, Downey JM. S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning. Am J Physiol. 1999;277:H2435-H2441.
72. ATP channels, and protein kinase C. J Am Coll Cardiol. 2002;40:1523-1530.
73. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz SD, Downey JM, Benoit JN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol. 2002;97:365-373.
74. ATP channels in rabbits. Am J Physiol Heart Circ Physiol. 2002;283: H1263-H1269.
75. ATP channel opener. Eur J Pharmacol. 2001;428:311-314.
76. Tanonaka K, Taguchi T, Koshimizu M, Ando T, Morinaka T, Yogo T, Konishi F, Takeo S. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/ reperfused heart. J Pharmacol Exp Ther. 1999;291:710-716.
77. + channels in the cardiac inner mitochondrial membrane. Science. 2002;298:1029-1033.
78. D'Hahan N, Moreau C, Prost AL, Jacquet H, Alekseev AE, Terzic A, Vivaudou M. Pharmacological plasticity of cardiac ATP-sensitive potassium channels toward diazoxide revealed by ADP. Proc Natl Acad Sci U S A. 1999;96:12162-12167.
79. + channel currents in guinea-pig single ventricular myocytes. Eur J Pharmacol. 1992;220: 35-41.
80. + channel by 5-hydroxydecanoate in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 1992;260:702-708.
81. ATP channels: triggers or distal effectors of ischemic or pharmacological preconditioning? Circ Res. 2000;87:431-433.
82. Schulz R, Gres P, Heusch G. Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs. Br J Pharmacol. 2003;139:65-72.
83. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992;26: 1054-1062.
84. ATP channel opening is important during index ischemia and following myocardial reperfusion in ischemic preconditioned rat hearts. J Mol Cell Cardiol. 2001;33: 831-834.
85. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol. 2001;280:H246-H255.
86. ATP channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide. J Mol Cell Cardiol. 2001;33: 2037-2046.
87. ATP. Basic Res Cardiol. 2000;95:243-249.
88. ATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res. 1999;85:1146-1153.
89. O'Rourke B, Ramza BM, Marbán E. Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science. 1994;265:962-966.
90. Billman GE, Englert HC, Scholkens BA. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel, part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther. 1998;286:1465-1473.
91. Grover GJ, Sleph PG, Dzwonczyk S. Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol. 1990;16:853-864.
92. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891. Eur J Pharmacol. 1990;191:11-18.
93. McCullough JR, Normandin DE, Conder ML, Sleph PG, Dzwonczyk S, Grover GJ. Specific block of the anti-ischemic actions of cromakalim by sodium 5-hydroxydecanoate. Circ Res. 1991;69:949-958.
94. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 1994;89:1769-1775.
95. ATP opener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 1995;26: 145-152.
96. + blocker dofetilide. Am J Physiol. 1996;271:H1207-H1214.
97. ATP channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002;109:509-516.
98. Suzuki M, Saito T, Sato T, Tamagawa M, Miki T, Seino S, Nakaya H. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice. Circulation. 2003;107:682-685.
99. ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res. 2000;45:934-940.
100. ATP channel in preservation of mitochondrial function. Am J Physiol Heart Circ Physiol. 2000;278: H305-H312.
101. ATP channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits. Naunyn Schmiedebergs Arch Pharmacol. 2000;361: 445-451.
102. Kass DA, Hare JM, Georgakopoulos D. Murine cardiac function: a cautionary tail. Circ Res. 1998;82:519-522.
103. ATP channels in ischemic preconditioning of the canine heart. Am J Physiol Heart Circ Physiol. 2001;280:H256-H263.
104. ATP channels. Naunyn Schmiedebergs Arch Pharmacol. 2001;364: 226-232.
105. ATP channels during metabolic inhibition and recovery. FASEB J. 2001;15:2586-2594.
106. Halestrap AP. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. Biochim Biophys Acta. 1989;973:355-382.
107. Akao M, O'Rourke B, Kusuoka H, Teshima Y, Jones SP, Marbán E. Differential actions of cardioprotective agents on the mitochondrial death pathway. Circ Res. 2003;92:195-202.
108. ATP channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics? Circ Res. 2000;87:915-921.
109. Park JW, Chun YS, Kim YH, Kim CH, Kim MS. Ischemic preconditioning reduces Op6 generation and prevents respiratory impairment in the mitochondria of post-ischemic reperfused heart of rat. Life Sci. 1997;60:2207-2219.
110. + channel protects the ischemic heart. Am J Physiol Heart Circ Physiol. 2002;283:H284-H295.
111. 2+ overload in rat cardiac mitochondria. J Physiol (Lond). 1999;519(pt 2):347-360.
112. ATP channels. Am J Physiol Heart Circ Physiol. 2001;280:H2321-H2328.
113. Korge P, Honda HM, Weiss JN. Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci U S A. 2002;99:3312-3317.
114. Akao M, Ohler A, O'Rourke B, Marbán E. Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res. 2001;88:1267-1275.
115. ATP channel activation reduces anoxic injury by restoring mitochondrial membrane potential. Am J Physiol Heart Circ Physiol. 2001;281:H1295-H1303.
116. ATP channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol. 2001; 33:2007-2014.
117. Akao M, Teshima Y, Marbán E. Antiapoptotic effect of nicorandil mediated by mitochondrial ATP-sensitive potassium channels in cultured cardiac myocytes. J Am Coll Cardiol. 2002;40:803-810.
118. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab. 2002;22:431-443.
119. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-543.
120. Akao M, O'Rourke B, Teshima Y, Seharaseyon J, Marbán E. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes. Circ Res. 2003;92:186-194.
121. ATP channels in preconditioning. J Mol Cell Cardiol. 2003;35:569-575.
122. Forbes RA, Steenbergen C, Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res. 2001;88:802-809.
123. Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT. Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem. 1998;273:18092-18098.
124. ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-466.
125. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guc Y, Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
126. Bolli R, Dawn B, Tang XL, Qiu Y, Ping P, Xuan YT, Jones WK, Takano H, Guo Y, Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol. 1998;93:325-338.
127. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001;33: 1897-1918.
128. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 1987;84:1404-1407.
129. Vanden Hoek TL, Becker LB, Shao ZH, Li CQ, Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res. 2000;86:541-548.
130. Paliwal R, Costa G, Diwan JJ. Purification and patch clamp analysis of a 40-pS channel from rat liver mitochondria. Biochemistry. 1992;31: 2223-2229.
131. ATP channels. Mol Pharmacol. 2001;59:225-230.
132. + channels in mitochondria. Biochem Biophys Res Commun. 1997;241:693-697.
133. + uniports induced by magnosium depletion. Int J Biochem Cell Biol. 1996;28:863-871.
134. Szewczyk A, Wojcik G, Lobanov NA, Nalecz MJ. The mitochondrial sulfonylurea receptor: identification and characterization. Biochem Biophys Res Commun. 1997;230:611-615.
135. + channel. Life Sci. 1992;51:1851-1856.